Covered recipient · General Payments record
AMY MCLAIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$1,489.52
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $629.01 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $185.90 | 9 |
| PFIZER INC. | $136.52 | 8 |
| Novo Nordisk AS | $81.95 | 5 |
| Lilly USA, LLC | $72.88 | 4 |
| Abbott Laboratories | $54.77 | 3 |
| ABBVIE INC. | $43.97 | 2 |
| Merck Sharp & Dohme Corporation | $21.31 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.21 | 1 |
| Acerta Pharma LLC | $13.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.07 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125088678 | CMS |
| Abbott Laboratories | $14.12 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125088680 | CMS |
| Abbott Laboratories | $18.58 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125088682 | CMS |
| ABBVIE INC. | $17.66 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107637158 | CMS |
| ABBVIE INC. | $26.31 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107637160 | CMS |
| Amgen Inc. | $27.42 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626222 | CMS |
| Amgen Inc. | $19.80 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115920612 | CMS |
| Amgen Inc. | $17.01 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115920617 | CMS |
| Amgen Inc. | $15.98 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115920624 | CMS |
| Amgen Inc. | $27.50 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626224 | CMS |
| Amgen Inc. | $18.38 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115920582 | CMS |
| Amgen Inc. | $23.75 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115920600 | CMS |
| Amgen Inc. | $20.50 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115920592 | CMS |
| Amgen Inc. | $15.56 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115920605 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.50 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105554794 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.21 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118028266 | CMS |
| Lilly USA, LLC | $23.21 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135505970 | CMS |
| Lilly USA, LLC | $16.95 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135525291 | CMS |
| Lilly USA, LLC | $14.79 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135509536 | CMS |
| Lilly USA, LLC | $17.93 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135530327 | CMS |
| Merck Sharp & Dohme LLC | $21.31 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141608385 | CMS |
| Novo Nordisk Inc | $13.89 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100560239 | CMS |
| Novo Nordisk Inc | $16.28 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100612060 | CMS |
| Novo Nordisk Inc | $20.13 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100422092 | CMS |
| Novo Nordisk Inc | $18.51 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100634073 | CMS |
| Novo Nordisk Inc | $13.14 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100518625 | CMS |
| PFIZER INC. | $18.46 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131628777 | CMS |
| PFIZER INC. | $18.20 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131637198 | CMS |
| PFIZER INC. | $14.82 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131565595 | CMS |
| PFIZER INC. | $18.46 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131660764 | CMS |
| PFIZER INC. | $16.24 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131776129 | CMS |
| PFIZER INC. | $14.70 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131975777 | CMS |
| PFIZER INC. | $13.67 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132121880 | CMS |
| PFIZER INC. | $21.97 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131486906 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.